World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   8505 records for 2328 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
Not recruitingNCT02392910
Hospitalization & Mortality in Patients With Iron Deficiency CKD and HF Treated With i.v. Iron.
15/03/2015
Not RecruitingEUCTR2013-002238-19-RO
Umeclidinium bromide added onto fluticasone furoate/vilanterol in COPD – Study 1
06/03/2015
RecruitingRBR-6gphkr
CQAB149BAR01 - 24-week study to assess which treatment is safer and bring more benefits to patients with COPD (Chronic Obstructive Pulmonary Disease) combination budesonide / indacaterol vs fluticasone / salmeterol
04/03/2015
RecruitingNCT02394028
A Study of the Safety and Efficacy of Etrolizumab in Patients With Moderately to Severely Active Crohn's Disease
27/02/2015
Not recruitingNCT02369016
Phase III Copanlisib in Rituximab-refractory iNHL
17/02/2015
RecruitingNCT02367794
A Phase III Study of MPDL3280A (Anti-PD-L1) in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-paclitaxel Compared With Carboplatin + Nab-paclitaxel in Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)
13/02/2015
Not recruitingNCT02367040
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
12/02/2015
RecruitingNCT02366143
A Phase III Study of MPDL3280A (Anti-PD-L1 Antibody) in Combination With Carboplatin + Paclitaxel With or Without Bevacizumab in Patients With Stage IV Non-squamous Non-small Cell Lung Cancer
12/02/2015
AuthorisedEUCTR2014-003041-10-EE
This study is to find out if ranibizumab is safe and effective compared to laser therapy in preterm babies with ROP, a condition of abnormal blood vessel (arteries and veins) development in the eyes
11/02/2015
RecruitingNCT02362503
Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients
09/02/2015
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history